Skip to main content
Clinical Trials/NCT04547478
NCT04547478CompletedNot Applicable

Evaluation of Low Muscle Mass by Muscle Surface Index of First Lumbar Vertebrae Using Low Dose Computed Tomography

Far Eastern Memorial Hospital1 site in 1 country3,304 target enrollmentStarted: January 21, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
3,304
Locations
1
Primary Endpoint
Cross sectional muscle area of the 1st vertebrae level

Study Overview

Brief Summary

The first lumbar spine muscle index (L1 MI) on computed tomography (CT) obtained by measuring muscle surface at the first lumbar vertebrae (L1) level is an indicator of total skeletal mass in specific populations. Nevertheless, the utility of L1 MI derived from low dose chest CT (LDCT) in health assessments and relevant cutoff points are unclear.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adults older than 20 years who received LDCT in routine health assessments from January to December 2017 were enrolled at a tertiary care hospital (Far Eastern Memorial Hospital, New Taipei City, Taiwan).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cross sectional muscle area of the 1st vertebrae level

Time Frame: 52 weeks

Cross sectional muscle area of the 1st vertebrae level by LDCT

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials